$BRVE

$21.87 +$0.43 (2.01%) Close

$BRVE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 90.0M shares outstanding

Who owns BRVE?

By type of holder

Institutions 0.0% Insiders 71.9% Everyone else 28.1%

Concentration Top 10 holders own 102.6%

Orbimed Advisors LLC 13.5% · OrbiMed Capital GP IX LLC 13.2%

Institutional ownership

0.0%

0.0 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

by institutions in Q2 2026

New / sold out

0 / 0

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

No 13F manager has reported this stock in the last 8 quarters.

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Braveheart Bio, Inc. in the last 12 months.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for Braveheart Bio, Inc..

How patient are the owners?

No 13F manager reports holding BRVE.

Super Investors

Investment managers reporting BRVE on Form 13F

No 13F manager reports holding BRVE yet.

Institutional Funds

Mutual funds and ETFs reporting BRVE on Form N-PORT; together they hold 3.5% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
FG Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust	$19.9M	779.6K	0.87%	0.02%	August 31, 2026
SA Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II	$15.3M	600.0K	0.67%	0.01%	August 31, 2026

Fidelity Growth Company Fund

Fidelity Mt. Vernon Street Trust

Position value

$19.9M

% of company

0.87%

% of the fund

0.02%

As of

August 31, 2026

Strategic Advisers Fidelity U.S. Total Stock Fund

Fidelity Rutland Square Trust II

Position value

$15.3M

% of company

0.67%

% of the fund

0.01%

As of

August 31, 2026

11 more funds behind a free account

See every fund holding Braveheart Bio, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
OA Orbimed Advisors LLC 5%+ holder 13D · 13.5%	12.2M	13.52%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company13.520% Disclosed stake13D · 13.5% View the 13D/G filing →
OC OrbiMed Capital GP IX LLC 5%+ holder 13D · 13.2%	11.9M	13.22%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company13.220% Disclosed stake13D · 13.2% View the 13D/G filing →

Orbimed Advisors LLC

5%+ holder13D · 13.5%

12.2M

% of company

13.52%

Change vs last qtr

—

Held since

—

OrbiMed Capital GP IX LLC

5%+ holder13D · 13.2%

11.9M

% of company

13.22%

Change vs last qtr

—

Held since

—

15 more holders behind a free account

See every insider and 5%+ holder of Braveheart Bio, Inc..

Comments